135. Aicardi syndrome Disease details / Clinical trials / Drug dev / DR info /

Clinical trial : 1 / Drugs : 9 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0

Drugs and their primary sponsors and trial info

Abacavir
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
Epivir
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
GX 623
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
GX CJ7
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
J05A F01
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
Lamivudine
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
Retrovir
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
Ziagen
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;
Zidovudine
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2014-002710-23-FR   France;